SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-23-031250
Filing Date
2023-02-10
Accepted
2023-02-10 07:02:51
Documents
145
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d443725d10k.htm   iXBRL 10-K 4310880
2 EX-10.3 d443725dex103.htm EX-10.3 36351
3 EX-10.6 d443725dex106.htm EX-10.6 272015
4 EX-10.7 d443725dex107.htm EX-10.7 10227
5 EX-10.31 d443725dex1031.htm EX-10.31 4851
6 EX-21 d443725dex21.htm EX-21 7964
7 EX-23 d443725dex23.htm EX-23 2151
8 EX-31.1 d443725dex311.htm EX-31.1 8455
9 EX-31.2 d443725dex312.htm EX-31.2 10376
10 EX-32 d443725dex32.htm EX-32 4211
16 GRAPHIC g443725g0131062048994.jpg GRAPHIC 1869
17 GRAPHIC g443725g0131064802021.jpg GRAPHIC 1869
18 GRAPHIC g443725g25p48.jpg GRAPHIC 59214
  Complete submission text file 0001193125-23-031250.txt   20298564

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA teva-20221231.xsd EX-101.SCH 138219
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE teva-20221231_cal.xml EX-101.CAL 85499
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE teva-20221231_def.xml EX-101.DEF 824449
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20221231_lab.xml EX-101.LAB 911455
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20221231_pre.xml EX-101.PRE 889947
139 EXTRACTED XBRL INSTANCE DOCUMENT d443725d10k_htm.xml XML 4377701
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-16174 | Film No.: 23608529
SIC: 2834 Pharmaceutical Preparations